Publicaciones en colaboración con investigadores/as de Federal Institute for Drugs and Medical Devices (2)

2021

  1. The EMA assessment of avapritinib in the treatment of gastrointestinal stromal tumours harbouring the PDGFRA D842V mutation

    ESMO Open, Vol. 6, Núm. 3

2020

  1. EMA Review of Daratumumab (Darzalex) for the Treatment of Adult Patients Newly Diagnosed with Multiple Myeloma

    Oncologist, Vol. 25, Núm. 12, pp. 1067-1074